Literature DB >> 10028079

Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.

V G Fowler1, L L Sanders, L K Kong, R S McClelland, G S Gottlieb, J Li, T Ryan, D J Sexton, G Roussakis, L J Harrell, G R Corey.   

Abstract

Fifty-nine consecutive patients with definite Staphylococcus aureus infective endocarditis (IE) by the Duke criteria were prospectively identified at our hospital over a 3-year period. Twenty-seven (45.8%) of the 59 patients had hospital-acquired S. aureus bacteremia. The presumed source of infection was an intravascular device in 50.8% of patients. Transthoracic echocardiography (TTE) revealed evidence of IE in 20 patients (33.9%), whereas transesophageal echocardiography (TEE) revealed evidence of IE in 48 patients (81.4%). The outcome for patients was strongly associated with echocardiographic findings: 13 (68.4%) of 19 patients with vegetations visualized by TTE had an embolic event or died of their infection vs. five (16.7%) of 30 patients whose vegetations were visualized only by TEE (P < .01). Most patients with S. aureus IE developed their infection as a consequence of a nosocomial or intravascular device-related infection. TEE established the diagnosis of S. aureus IE in many instances when TTE was nondiagnostic. Visualization of vegetations by TTE may provide prognostic information for patients with S. aureus IE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028079     DOI: 10.1086/515076

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  32 in total

1.  Staphylococcus aureus Endocarditis in the 21st Century.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Echocardiography for the Diagnosis of Staphylococcus aureus Infective Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

3.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

4.  Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.

Authors:  G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-25       Impact factor: 3.267

5.  Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.

Authors:  Kati Seidl; Arnold S Bayer; Vance G Fowler; James A McKinnell; Wessam Abdel Hady; George Sakoulas; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

6.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

7.  Contribution of echocardiography in the diagnosis of definitive infective endocarditis: the infectious disease specialist's point of view.

Authors:  B Davido; A Moussiegt; A Dinh; O Senard; L Deconinck; O Auzel; X Repesse; M Sirol; M Morgan; J Salomon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-18       Impact factor: 3.267

Review 8.  Infective Endocarditis in the Elderly: Diagnostic and Treatment Options.

Authors:  M P Ursi; E Durante Mangoni; R Rajani; J Hancock; J B Chambers; B Prendergast
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

Review 9.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Comparison between transthoracic and transesophageal echocardiography in screening for infective endocarditis in patients with Staphylococcus aureus bacteremia.

Authors:  D Wong; Y Keynan; E Rubinstein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.